LINC02210-CRHR1

Across TCGA pan-cancer cohorts, LINC02210-CRHR1 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated LINC02210-CRHR1 data layer.

The strongest signal is observed in brain lower grade glioma (LGG), where higher LINC02210-CRHR1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated LINC02210-CRHR1 expression acts as an unfavorable survival marker, although some lineages such as LGG and KIRC show a favorable association.

LGG, KIRP, and LUSC are the cancer types where LINC02210-CRHR1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LGG	OS	Median	All	0.875	0.750	<.001	40	view →
KIRP	OS	Tertile	All	0.826	0.944	.004	39	view →
LUSC	OS	Tertile	IV	0.001	0.673	.014	36	view →
KIRC	DFS	Tertile	IV	0.848	0.458	.016	30	view →
LAML	DFS	Tertile	All	0.112	0.582	.010	18	view →
LIHC	DFS	Tertile	All	0.123	0.530	.009	18	view →
LUAD	DFS	Tertile	All	0.922	0.746	.035	12	view →
STAD	DFS	Tertile	IV	0.083	0.379	.001	9	view →
COAD	DFS	Tertile	IV	0.099	0.515	.010	9	view →
PCPG	DFS	Median	All	0.972	0.872	.019	2	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

LINC02210-CRHR1–LGG (OS)

Open the LGG breakdown →